Mania following use of ibogaine: A case series
Safety (cardiac & more) Case series high
AI-extracted · unverified · confirm at source
SAFETY ALERT: 3 cases de novo mania post-ibogaine, no prior bipolar history. Onset days-to-weeks post-use. Stimulant-induced mania excluded by tox; opiate withdrawal dismissed via Mr. C's opiate-naive history. First published mania reports.
Dosing: Unknown in all three cases (unregulated settings; doses not reported or verified) (oral)
Sample size: 3
Contraindications: Personal or family history of bipolar disorder or mania, Prior manic or psychotic episodes, Concurrent or recent psilocybin use (confounding psychiatric risk), Unregulated treatment setting without psychiatric monitoring or follow-up